Back to search

University of Nevada - Reno

Muscular dystrophy: from mouse models to small molecule therapies

Abstract

dc:description.abstract

Muscular dystrophy (MD) is a group of genetic diseases that primarily affects the muscular tissue and is characterized by progressive muscle wasting and weakness. MDs can be classified according to the age of onset, clinical symptoms, and the mutated genes with their respective encoded proteins. According to the age of onset, MDs are divided into congenital muscular dystrophies presenting early onset at birth or within the first six months of life, and late-onset muscular dystrophies characterized by the onset after the first years of life. Currently, there is no cure or effective treatment to prevent muscular dystrophy disease progression. In this dissertation, we characterized the cardiac function in humans and a mouse model of integrin α7-related congenital muscular dystrophy (ITGA7-CMD), a rare type of congenital muscular dystrophy, and verified the loss of integrin α7 is associated with late-onset cardiomyopathy in ITGA7-CMD patients and Itga7-/- mouse model. Additionally, we investigated the efficacy of two FDA-approved small molecule drugs, sunitinib and vemurafenib, for the treatment of Duchenne muscular dystrophy (DMD) and laminin-α2-related congenital muscular dystrophy (LAMA2-CMD), respectively. Our results show that treatment with sunitinib prevents DMD-related cardiomyopathy progression by improving cardiac histopathology and function in a mouse model of DMD, and treatment with vemurafenib improves skeletal muscle histopathology by regulating fibrosis and metabolism in a mouse model of LAMA2-CMD. Together our results highlight the importance of using animal models to understand the molecular mechanisms of the disease and develop new therapies for different types of MDs.

Degree

thesis:*
Level thesis:degree_level
Doctorate Degree
Department thesis:degree_department
Cell and Molecular Pharmacology and Physiology
Year dc:date.issued
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Oliveira Santos Nicolich, Ariany
Advisor dc:contributor.advisor
  • Burkin, Dean DB
Committee members dc:contributor.committeemember
  • Ba, Mariam MB
  • Ferguson, Bradley BF
  • Leblanc, Normand NL
  • Harvey, Robert RH

Subjects

dc:subject × 5

Rights

dc:rights
Statement dc:rights
  • Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 United States
  • Author(s)

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/11714/8352

Chain of custody

source
Harvested from
University of Nevada - Reno
Base URL
scholarwolf.unr.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Oliveira Santos Nicolich, Ariany. Muscular dystrophy: from mouse models to small molecule therapies. Doctorate Degree thesis, 2022. http://hdl.handle.net/11714/8352